Sivan Innovation
Cancer Monitoring and Management Platform
Company Overview
Snapshot
Founded in June 2014 by Daniel Israel, Sivan Innovation operates with 1–10 employees. The company is recognized for its digital therapy, Moovcare, which has demonstrated an increase of 7.6 months in overall survival for lung cancer patients and is reimbursed by health authorities in France.
Business overview
Sivan Innovation develops web applications for disease management, serving healthcare professionals and patients. Its core product, Moovcare, is a digital therapy designed for cancer patients that utilizes a smart algorithm to detect relapses and complications, sending immediate alerts to medical teams. The application enables lung cancer patients to report symptoms via a weekly digital questionnaire, facilitating timely intervention by oncologists. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Patient Remote Monitoring, and Digital Therapeutics, leveraging mobile platforms and artificial intelligence.
Log in to access full profile ›Company Intelligence Q&A
- What is Sivan Innovation's primary product?
- Sivan Innovation's primary product is Moovcare, a digital therapy designed for cancer patients. It uses a smart algorithm to detect relapses and complications, alerting medical teams.
- Which markets does Sivan Innovation serve?
- Sivan Innovation serves healthcare professionals and patients in geomarkets including Germany, the United States, France, and Israel.
- What is the reported impact of Moovcare on patient outcomes?
- Moovcare has demonstrated an increase of 7.6 months in overall survival for lung cancer patients, along with a significant improvement in their quality of life.
- Is Moovcare reimbursed by health authorities?
- Yes, Moovcare is reimbursed by health authorities in France.
- Who is the founder of Sivan Innovation?
- Sivan Innovation was founded by Daniel Israel.